Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer.
Torres-Ruiz S, Garrido-Cano I, Lameirinhas A, Burgués O, Hernando C, Martínez MT, Rojo F, Bermejo B, Tapia M, Carbonell-Asins JA, Peña CJ, Lluch A, Cejalvo JM, Tormo E, Eroles P. Torres-Ruiz S, et al. Among authors: hernando c. Cell Death Discov. 2024 Aug 22;10(1):372. doi: 10.1038/s41420-024-02128-7. Cell Death Discov. 2024. PMID: 39174500 Free PMC article.
Gestational breast cancer: distinctive molecular and clinico-epidemiological features.
de la Haba-Rodríguez JR, Mínguez P, Rojo F, Martín M, Alba E, Servitja S, Prat A, Pérez-Fidalgo JA, Gavilá J, Morales C, Rodriguez-Lescure A, Herrero C, Peña-Enriquez R, Herranz J, Hernando C, Hernández-Blanquisett A, Guil-Luna S, Martinez MT, Blanch S, Caballero R, Martín N, Pollán M, Guerrero-Zotano A, Bermejo B. de la Haba-Rodríguez JR, et al. Among authors: hernando c. J Mammary Gland Biol Neoplasia. 2024 Nov 8;29(1):18. doi: 10.1007/s10911-024-09571-3. J Mammary Gland Biol Neoplasia. 2024. PMID: 39514034 Free PMC article.
Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study.
Tolosa P, Pascual T, Martínez-Saez O, Hernando C, Servitja S, Fernández Abad M, Brasó-Maristany F, Sanfeliu E, Benitez Fuentes JD, Lema L, Ruano Y, García-Fructuoso I, Parrilla L, Rodríguez A, Roncero AM, Cobos MÁ, Sánchez-Bayona R, Alva M, Madariaga A, Villacampa G, Canes J, Salvador F, Sánchez-Belmonte A, Malumbres M, Prat A, Ciruelos E. Tolosa P, et al. Among authors: hernando c. Eur J Cancer. 2025 Jan 3:115219. doi: 10.1016/j.ejca.2024.115219. Online ahead of print. Eur J Cancer. 2025. PMID: 39779447
Prehabilitation Consultation on Self-Care and Physical Exercise in Patients Diagnosed with Abdominopelvic Cancer: Protocol of the Study.
Suárez-Alcázar MP, Collado-Boira EJ, Recacha-Ponce P, Salas-Medina P, García-Roca ME, Hernando C, Muriach M, Baliño P, Flores-Buils R, Martínez Latorre ML, Sales-Balaguer N, Folch-Ayora A. Suárez-Alcázar MP, et al. Among authors: hernando c. Healthcare (Basel). 2024 Jul 16;12(14):1423. doi: 10.3390/healthcare12141423. Healthcare (Basel). 2024. PMID: 39057566 Free PMC article.
Exercise and Quality of Life (QoL) in Patients Undergoing Active Breast Cancer Treatment-Comparison of Three Modalities of a 24-Week Exercise Program-A Randomized Clinical Trial.
Suárez-Alcázar MP, García-Roca ME, Collado-Boira EJ, Recacha-Ponce P, Temprado-Albalat MD, Baliño P, Muriach M, Flores-Buils R, Salas-Medina P, Hernando C, Folch-Ayora A. Suárez-Alcázar MP, et al. Among authors: hernando c. Healthcare (Basel). 2024 May 29;12(11):1107. doi: 10.3390/healthcare12111107. Healthcare (Basel). 2024. PMID: 38891182 Free PMC article.
Effect of a Long-Term Online Home-Based Supervised Exercise Program on Physical Fitness and Adherence in Breast Cancer Patients: A Randomized Clinical Trial.
Garcia-Roca ME, Catalá-Vilaplana I, Hernando C, Baliño P, Salas-Medina P, Suarez-Alcazar P, Folch-Ayora A, Collado Boira E. Garcia-Roca ME, et al. Among authors: hernando c. Cancers (Basel). 2024 May 17;16(10):1912. doi: 10.3390/cancers16101912. Cancers (Basel). 2024. PMID: 38791989 Free PMC article.
A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results.
Hamilton E, Oliveira M, Turner N, García-Corbacho J, Hernando C, Ciruelos EM, Kabos P, Ruiz-Borrego M, Armstrong A, Patel MR, Vaklavas C, Twelves C, Boni V, Incorvati J, Brier T, Gibbons L, Klinowska T, Lindemann JPO, Morrow CJ, Sykes A, Baird RD. Hamilton E, et al. Among authors: hernando c. Ann Oncol. 2024 Aug;35(8):707-717. doi: 10.1016/j.annonc.2024.04.012. Epub 2024 May 8. Ann Oncol. 2024. PMID: 38729567 Free article. Clinical Trial.
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study.
Sampedro-Nuñez M, Herrera-Martínez AD, Ibáñez-Costa A, Rivero-Cortés E, Venegas E, Robledo M, Martínez-Hernández R, García-Martínez A, Gil J, Jordà M, López-Fernández J, Gavilán I, Maraver S, Marqués-Pamies M, Cámara R, Fajardo-Montañana C, Valassi E, Dios E, Aulinas A, Biagetti B, Álvarez Escola C, Araujo-Castro M, Blanco C, Paz M, Villar-Taibo R, Álvarez CV, Gaztambide S, Webb SM, Castaño L, Bernabéu I, Picó A, Gálvez MÁ, Soto-Moreno A, Puig-Domingo M, Castaño JP, Marazuela M, Luque RM; REMAH investigators. Sampedro-Nuñez M, et al. Eur J Endocrinol. 2024 Jun 5;190(6):421-433. doi: 10.1093/ejendo/lvae045. Eur J Endocrinol. 2024. PMID: 38701338
121 results